Comparison between mono‐tacrolimus and mono‐glucocorticoid in the treatment of myasthenia gravis

Comparison between mono‐tacrolimus and mono‐glucocorticoid in the treatment of myasthenia gravis

Abstract Objective Use of tacrolimus in mild to moderate myasthenia gravis (MG) is generally limited to glucocorticoid‐refractory cases; the advantage of mono‐tacrolimus over mono‐glucocorticoids is unknown. Methods We included mild to moderate MG patients treated with mono‐tacrolimus (mono‐TAC) or...

Full description

Bibliographic Details
Main Authors: Zhirong Fan, Lin Lei, Shengyao Su, Shu Zhang, Nairong Xie, Ling Li, Yan Lu, Li Di, Min Wang, Min Xu, Xin‐Ming Shen, Yuwei Da
Format: Article
Language:English
Published: Wiley 2023-04-01
Series:Annals of Clinical and Translational Neurology
Online Access:https://doi.org/10.1002/acn3.51746

Similar Items

Similar Items